Can psoriasis patients skip more shots? new trial tests extended guselkumab dosing
Disease control
Completed
This study tested whether people with moderate-to-severe plaque psoriasis who achieve complete skin clearance after 20 weeks of guselkumab (Tremfya) can maintain that control with injections every 16 weeks instead of every 8 weeks. About 880 participants were enrolled, and the ma…
Phase: PHASE3 • Sponsor: Janssen-Cilag International NV • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC